Sotatercept (Winrevair; Merck) is enhancing treatment for patients with pulmonary arterial hypertension (PAH), explained ...

The small-profile device expands to capture clots like large-bore systems while offering good reduction in RV/LV ratio at 48 ...

Sotatercept (Winrevair) represents the first new mechanism of action for pulmonary arterial hypertension (PAH) treatment in over a decade, offering hope for patients with this life-threatening ...

Pulmonary hypertension is traditionally defined as a mean pulmonary artery pressure of ≥25 mmHg when a patient is at rest, though a mean pressure of >20 mm Hg is considered to be abnormal and may ...

November is Pulmonary Hypertension Awareness Month, and the American Lung Association, with support from Merck, is raising awareness about one form of the condition: pulmonary arterial hypertension ...

Acute pulmonary embolism is a life-threatening condition because it places sudden strain on the right ventricle of the heart.

This transcript has been edited for clarity. Vallerie McLaughlin, MD: Hello and welcome to this Medscape InDiscussion on pulmonary arterial hypertension (PAH). Our topic today is the very important ...

Please provide your email address to receive an email when new articles are posted on . Engagement in daily pulmonary artery pressure readings may benefit patients with heart failure. Patients made ...

In March, we reported on back-to-back FDA approvals for two treatments in pulmonary arterial hypertension (PAH). In this report, we follow up on what has happened since. After the FDA approved both ...

Editor’s note: This is an automatically generated transcript. Please notify [email protected] if there are concerns regarding accuracy of the transcription. This is something I'm particularly ...

Doctors at Rome's Sant'Andrea hospital have performed a pulmonary artery transplant on a patient in their 70s with lung ...